| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/08/1997 | EP0751783A1 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic aminoacetylmercapto derivatives |
| 01/08/1997 | EP0751775A1 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide derivatives |
| 01/08/1997 | EP0751774A1 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide disulfide derivatives |
| 01/08/1997 | EP0751709A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 01/08/1997 | CN1139932A N-terminally chemically modified protein compositions and methods |
| 01/08/1997 | CN1139928A Novel compound |
| 01/08/1997 | CN1139917A Calcium receptor-active arylalkyl amines |
| 01/08/1997 | CN1139666A Novel tricyclic amide, its preparation method and medicinal combination |
| 01/08/1997 | CN1033750C Intermediates useful in the production of aromatic amino-alcohol derivatives having antidiabetes and antiobesity properties |
| 01/07/1997 | US5591775 Sleep disorders |
| 01/07/1997 | US5591772 Dietary supplements |
| 01/07/1997 | US5591763 Imidazoles |
| 01/07/1997 | US5591757 Dihydropyridine composition |
| 01/07/1997 | US5591454 Administering glipizide |
| 01/07/1997 | US5591450 L-carnitine salt and compositions containing same |
| 01/07/1997 | US5591437 Cosmetic or pharmeceutical composition containing a black horehound extract |
| 01/07/1997 | CA2079585C Ligand for the neu gene product |
| 01/03/1997 | WO1997000319A2 Chimeric leptin fused to immunoglobulin domain and use |
| 01/03/1997 | WO1997000242A1 Novel vitamin d derivatives with c-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments |
| 01/03/1997 | WO1997000088A2 Rotavirus enterotoxin nsp4 and methods of using same |
| 01/03/1997 | WO1997000063A2 Urocortin peptides |
| 01/03/1997 | WO1996037201A3 METHODS AND COMPOSITIONS FOR INHIBITING 5α-REDUCTASE ACTIVITY |
| 01/03/1997 | WO1996032003A3 Tetrahydroimidazopyridoindolediones and their use as medicaments |
| 01/03/1997 | CA2224697A1 Rotavirus enterotoxin nsp4 and methods of using same |
| 01/03/1997 | CA2224646A1 Chimeric leptin fused to immunoglobulin domain and use |
| 01/03/1997 | CA2224440A1 New vitamin d derivatives with substituents at c-25, process for their production, intermediate products and use for the production of pharmaceutical agents |
| 01/03/1997 | CA2223792A1 Urocortin peptides |
| 01/02/1997 | EP0750673A1 Transgenic production of oligosaccharides and glycoconjugates |
| 01/02/1997 | EP0750626A1 Corpuscles of stannius protein, stanniocalcin |
| 01/02/1997 | EP0750617A1 Novel heterocyclic ethanolamine derivatives with beta-adrenoreceptor agonistic activity |
| 01/02/1997 | EP0750614A1 Quinazolinyl-amino derivatives having alpha-antagonist activity |
| 01/02/1997 | EP0750511A1 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor |
| 01/02/1997 | EP0750509A1 Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases |
| 01/02/1997 | EP0750504A1 Use of complex carbohydrate to diminish hypoglycemia in patients with diabetes mellitus |
| 01/02/1997 | EP0750502A1 Use of phosphorus derivatives of alkaloids for treating endocrinopathies |
| 01/02/1997 | EP0750497A1 Uses of perillyl alcohol and perillic acid methyl ester |
| 12/31/1996 | US5589482 Benzo-thiophene estrogen agonists to treat prostatic hyperplasia |
| 12/31/1996 | US5589471 Vitamin D analogues containing a hydroxy or alkylated hydroxy group in the 20-position |
| 12/31/1996 | US5589468 Method for providing nutrition to elderly patients |
| 12/31/1996 | US5589452 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| 12/31/1996 | US5589374 Diabetogene rad: a type II diabetes specific gene |
| 12/31/1996 | US5589358 Ileal bile acid transporter compositions and methods |
| 12/31/1996 | CA1338824C Hypoglycemic and growth-promoting agent isolated from bacitracin |
| 12/27/1996 | WO1996041795A1 Benzamide derivatives and their use as vasopressin antagonists |
| 12/27/1996 | WO1996041645A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations |
| 12/27/1996 | WO1996041626A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 12/27/1996 | EP0750044A2 DNA constructs and transfection of cells therewith for homologous recombination |
| 12/27/1996 | EP0749964A1 N-Heterocyclyl biphenyl sulfonamides |
| 12/27/1996 | EP0749752A1 Use of specific RXR receptor ligands |
| 12/27/1996 | EP0749751A2 Pharmaceutical composition for use in tteatment of diabetes |
| 12/27/1996 | EP0749697A1 Coated food |
| 12/27/1996 | EP0749430A1 Thiazolidinedione derivatives as anti-hyperglycemic agents |
| 12/27/1996 | EP0749428A1 Isoxazoline compounds as inhibitors of tnf release |
| 12/27/1996 | EP0749423A1 Piperidines and pyrrolidines |
| 12/27/1996 | EP0749422A1 Indole derivatives as cck receptor antagonists |
| 12/27/1996 | EP0749307A1 Isoxazoline compounds as 5-lipoxygenase inhibitors |
| 12/27/1996 | EP0500853B1 Phenylethanolamines, drugs containing these compounds, and a method of preparing them |
| 12/27/1996 | CA2224563A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations |
| 12/27/1996 | CA2224517A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 12/27/1996 | CA2223869A1 Benzamide derivatives and their use as vasopressin antagonists |
| 12/25/1996 | CN1033639C Benzoquinonyl-containing thiazolidine compound preparing process |
| 12/24/1996 | US5587398 Affinity for serotonergic neurons; treating nervous system disorder; lipophilic |
| 12/24/1996 | US5587367 Pharmaceutical or cosmetic composition containing a combination of a retinoid and a sterol |
| 12/24/1996 | US5587309 Method of stimulating proliferation and differentiation of human fetal pancreatic cells ex vivo |
| 12/24/1996 | CA2030174C Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates |
| 12/24/1996 | CA2020752C Treatment of bone disorders |
| 12/23/1996 | CA2179696A1 Coated food |
| 12/20/1996 | CA2179426A1 Use of ligands specific to rxr receptors |
| 12/19/1996 | WO1996040894A1 Treatment of insulin resistance |
| 12/19/1996 | WO1996040863A1 Conversion of compactin to pravastatin by actinomadura |
| 12/19/1996 | WO1996040775A1 Method for the treatment of corticosteroid induced osteopenia |
| 12/19/1996 | WO1996040762A1 Monocyte chemotactic protein-4 |
| 12/19/1996 | WO1996040681A1 N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists |
| 12/19/1996 | WO1996040660A1 Certain substituted benzylamine derivatives: a new class of neuropeptide y1 specific ligands |
| 12/19/1996 | WO1996040651A1 Alkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| 12/19/1996 | WO1996040650A1 Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| 12/19/1996 | WO1996040649A1 Amino acid derivatives of substituted quinoxaline 2,3-dione derivatives as glutamate receptor antagonists |
| 12/19/1996 | WO1996040246A1 Treatment of t cell mediated autoimmune disorders |
| 12/19/1996 | WO1996040220A1 Treatment of type ii diabetes mellitus with amylin agonists |
| 12/19/1996 | WO1996040196A1 Appetite regulating compositions |
| 12/19/1996 | WO1996040194A1 Stable formulations of mhc-peptide complexes |
| 12/19/1996 | WO1996040193A1 CYCLIC ANALOGS OF PTH AND PTHrP |
| 12/19/1996 | WO1996040181A1 Processed ginseng having enhanced pharmacological effect |
| 12/19/1996 | WO1996040128A2 Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof |
| 12/19/1996 | WO1996040126A1 1h-4(5)-substituted imidazole derivatives |
| 12/19/1996 | WO1996040123A1 Antigen-processing cell-targeted conjugates |
| 12/19/1996 | WO1996040116A1 Indolinone compounds for the treatment of disease |
| 12/19/1996 | WO1996040099A1 Method for regulating glucose metabolism |
| 12/19/1996 | WO1996040098A2 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
| 12/19/1996 | WO1996040048A2 Novel uses for thyroid hormones or thyroid hormone-like compounds |
| 12/19/1996 | WO1996039996A1 Method for regulating metabolism with dopamine beta hydroxylase inhibitors |
| 12/19/1996 | CA2224099A1 Monocyte chemotactic protein-4 |
| 12/19/1996 | CA2223891A1 Treatment of insulin resistance |
| 12/19/1996 | CA2223832A1 Method for the treatment of corticosteroid induced osteopenia |
| 12/19/1996 | CA2223611A1 Appetite regulating compositions |
| 12/19/1996 | CA2223605A1 Stable formulations of mhc-peptide complexes |
| 12/19/1996 | CA2223499A1 Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof |
| 12/19/1996 | CA2223303A1 Treatment of t cell mediated autoimmune disorders |
| 12/19/1996 | CA2223122A1 Conversion of compactin to pravastatin by actinomadura |
| 12/19/1996 | CA2222652A1 1h-4(5)-substituted imidazole derivatives |